Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model

Polycystic ovary syndrome (PCOS) is highly associated with cardiometabolic risk and the metabolic syndrome (MetS), predisposing women to increased risk of developing type 2 diabetes and cardiovascular disease. Metformin is commonly used to treat insulin resistance-glucose intolerance, and flutamide,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Endocrinol Metab
Autors principals: Kupreeva, M., Diane, A., Lehner, R., Watts, R., Ghosh, M., Proctor, S., Vine, D.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6417686/
https://ncbi.nlm.nih.gov/pubmed/30153063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00018.2018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars